Cancer incidence and mortality in China, 2022
2024 · Journal of the National Cancer Center · 1,714 citations
https://doi.org/10.1016/j.jncc.2024.01.006
J
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
943
Papers
55.7K
Citations
90
h-index
486
i10-index
Jie He is an academic researcher from First Affiliated Hospital of Jinan University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Esophageal Cancer Research and Treatment. The author has an h-index of 90, co-authored 802 publications.
ORCID: 0000-0002-0285-5403Papers by this author
worksCuproptosis: mechanisms and links with cancers
2023 · Molecular Cancer · 683 citations
https://doi.org/10.1186/s12943-023-01732-y
[Cancer incidence and mortality in China, 2022].
2024 · PubMed · 405 citations
https://doi.org/10.3760/cma.j.cn112152-20240119-00035
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
2020 · Journal of Thoracic Oncology · 399 citations
https://doi.org/10.1016/j.jtho.2020.01.017
Perioperative Nivolumab in Resectable Lung Cancer
2024 · New England Journal of Medicine · 356 citations
https://doi.org/10.1056/nejmoa2311926
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
2021 · Nature Communications · 268 citations
https://doi.org/10.1038/s41467-021-27022-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat